Letters to the Editor

Surgery vs Corticosteroid Injections for Carpal Tunnel Syndrome

American Family Physician. 2026;113(2):110.

Author disclosure: No relevant financial relationships

To the Editor: We read with great interest the recent Medicine by the Numbers by Drs. Neubauer and Alisangco on surgical vs nonsurgical treatments for carpal tunnel syndrome.1 We agree with their findings and conclusions about the treatment of carpal tunnel syndrome, with one exception: “… evidence is uncertain about whether surgery vs corticosteroid injection results in beneficial long-term clinical improvement….”1

In 2005, we published a randomized clinical trial comparing local corticosteroid injections vs surgery in treating primary carpal tunnel syndrome (163 wrists).2 Follow-up occurred at 3, 6, and 12 months and 2 and 6 years posttreatment.3,4 At the 6-year follow-up, surgery appeared to be more effective than local corticosteroid injections. The accumulated incidence of therapeutic failure was 11.6% in the surgery group vs 41.8% in the injection group (see figure 1).4 Conversely, 58% of patients in the injection group did not need further therapeutic interventions during the 6-year follow-up period.

We believe that these results definitively support the superiority of surgery to local corticosteroid injections for carpal tunnel syndrome in the long term.

Diana Ly-Liu, MD, PhD

Bilbao, Spain

José-Luis Andréu, MD, PhD

Majadahonda, Madrid, Spain

Domingo Ly-Pen, MD, PhD

Cootehill, Cavan, Ireland

Author disclosure: No relevant financial relationships

  1. 1.Neubauer TM, Alisangco JB. Surgical vs nonsurgical treatments for carpal tunnel syndrome [Medicine by the Numbers]. Am Fam Physician. 2025;112(1):20-21.
  2. 2.Ly-Pen D, Andréu JL, de Blas G, et al. Surgical decompression versus local steroid injection in carpal tunnel syndrome: a one-year, prospective, randomized, open, controlled clinical trial. Arthritis Rheum. 2005;52(2):612-619.
  3. 3.Ly-Pen D, Andréu JL, Millán I, et al. Comparison of surgical decompression and local steroid injection in the treatment of carpal tunnel syndrome: 2-year clinical results from a randomized trial. Rheumatology (Oxford). 2012;51(8):1447-1454.
  4. 4.Ly-Pen D, Andreu JL, Millán I, et al. Long-term outcome of local steroid injections versus surgery in carpal tunnel syndrome: observational extension of a randomized clinical trial. Hand (N Y). 2022;17(4):639-645.

In Reply: We appreciate your response and your 2005 study that demonstrated a lower therapeutic failure rate for surgical decompression (11.6%) compared with local corticosteroid injection (41.8%) at 6 years.1 Notably, 58% of patients in the injection group did not require further intervention during this period, indicating that local corticosteroid injection offers durable benefits for a subset of patients.1 However, our Medicine by the Numbers focuses on the 2024 Cochrane review of 14 randomized trials of surgery compared with multiple nonsurgical interventions, including splinting, corticosteroid injection, platelet-rich plasma, and multimodal conservative care.2,3 The review highlights the uncertainty in direct comparisons between surgery and local corticosteroid injection, including for outcomes longer than 3 months. The review concluded that long-term clinical improvement and symptom relief differences between surgery and local corticosteroid injection remain uncertain.3

Thomas M. Neubauer, MD

Fort Carson, Colorado

Jason B. Alisangco, DO

Fort Jackson, South Carolina

Author disclosure: No relevant financial relationships

  1. 1.Ly-Pen D, Andréu JL, de Blas G, et al. Surgical decompression versus local steroid injection in carpal tunnel syndrome: a one-year, prospective, randomized, open, controlled clinical trial. Arthritis Rheum. 2005;52(2):612-619.
  2. 2.Neubauer TM, Alisangco JB. Surgical vs nonsurgical treatments for carpal tunnel syndrome [Medicine by the Numbers]. Am Fam Physician. 2025;112(1):20-21.
  3. 3.Lusa V, Karjalainen TV, Pääkkönen M, et al. Surgical versus non-surgical treatment for carpal tunnel syndrome. Cochrane Database Syst Rev. 2024(1):CD001552.

Author disclosure: No relevant financial relationships

Email letter submissions to afplet@aafp.org. Letters should be fewer than 400 words and limited to six references, one table or figure, and three authors. Letters submitted for publication in AFP must not be submitted to any other publication. Letters may be edited to meet style and space requirements.

This series is coordinated by Kenny Lin, MD, MPH, deputy editor.

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.